Keywords
Biomedical industry
Sustainable development
Submitted : 2024-02-07
Accepted : 2024-02-22
Published : 2024-03-08
Abstract
There is a growing global awareness of environmental, social, and governance (ESG) concerns. The biopharmaceutical industry is an important field that affects human health and well-being, and its sustainable development is now the industry’s focus. Based on the current state of the green development of China’s biopharmaceutical industry, the article proposes suggestions and paths for promoting the industry to better fulfill its social responsibilities and protect the environment while pursuing economic benefits. By doing so, the industry can make a greater contribution to global public health and become an important factor in promoting human health and social prosperity.
References
Hu P, Zhang Z, Ning J, et al., 2023, Construction of a Collaborative Scientific and Technological Innovation Achievement Transformation System – Experience of Central South University Xiangya Hospital. Chinese Research Hospitals, 10(4): 20–24.
Zhang J, Wang X, Sha C, et al., 2023, Research on Constructing Digital Infrastructure Systems for Biomedical R&D. Chinese Engineering Science, 25(5): 92–102.
Li J, Shen J, Chen M, 2023, Evolutionary Dynamics of Biomedical Innovation Clusters in the Yangtze River Delta. Science and Technology Management Research, 43(20): 197–204.
Ge Y, Fang Z, Zhang Y, et al., 2023, The Achievements and Prospects of the “Modernization Research of Traditional Chinese Medicine” Project During the “Thirteenth Five-Year Plan” Period to Support Research on the Sustainable Utilization and Development of Traditional Chinese Medicine Resources. Modern Chinese Medicine in China, 25(10): 2061–2064.
Liang L, 2023, Health-Centered Medical Model and Transformation of Medical and Health Science and Technology Innovation Achievements. Health Examination and Management, 4(3): 299–302.
Li X, Liu Z, 2023, Research on the Financial Performance of the Pharmaceutical and Biological Industry from the Perspective of ESG Disclosure. Business Accounting, 2023(10): 49–54.
Zhang J, 2023, Thoughts and Suggestions on the Sustainable Development of “Chinese Medicine Valley” in Zhumadian City. Henan Agriculture, 2023(13): 54–55.
Zhang R, Hu Q, Gao Y, et al., 2022, Research on the Biopharmaceutical Industry Development Strategies in Yunnan Province from the Biodiversity Perspective. China Science and Technology Resources Guide, 54(6): 85–91.
Liu R, Wu W, Zhu Y, et al., 2022, Progress and Prospects of Modern Research Methods for Animal Drugs. Journal of Nanjing University of Chinese Medicine, 38(10): 857–869.
Ma Y, 2022, The Biomanufacturing Industry is the Key Development Direction of the Economy. Chinese Journal of Bioengineering, 42(5): 4–5.
Pu A, Liu Q, Guo S, et al., 2022, Evolution Rules of the Global Economy and Suggestions for Countermeasures for Developing China’s Economy. Chinese Journal of Bioengineering, 42(5): 146–153.
Jiang W, Zhang J, Guo L, et al., 2022, Ideas and Suggestions for the Ecological Development of the Gastrodia elata Planting Industry. Chinese Journal of Traditional Chinese Medicine, 47(9): 2277–2280.
Liu C, 2022, Taking Stock of 2021: A Brief View on the Innovative Development of Biomedicine in China. China Pharmaceutical, 31(4): 1–7.
Li J, Ge Y, Gao L, 2022, Research on the Dynamic Mechanism of the Evolution of Innovation Clusters in China’s Biomedical Industry – Based on Complex Adaptive System Theory. Science and Technology Management Research, 42(3): 176–183.
Huang L, Pan C, Guan X, et al., 2021, Thoughts on the Current Status of Marine Medicinal Organism Research and Industrial Development in Guangxi. Fisheries Research, 43(6): 651–660.
Robinson K, 2023, Overcoming Bio/pharmaceutical Production Hurdles: An Industry Insider Perspective. Manufacturing Chemist, viewed 26 Dec 2023, https://www.manufacturingchemist.com/overcoming-bio-pharmaceutical-production-hurdles-an-industry-insider-perspective
Strauss D, Ghosh S, Murray Z, et al., 2022, Psilocybin Containing Mushrooms: A Rapidly Developing Biotechnology Industry in the Psychiatry, Biomedical and Nutraceutical Fields. 3 Biotech, 12(12): 339. https://doi.org/10.1007/s13205-022-03355-4
Debon A, Siirola E, Snajdrova R, 2023, Enzymatic Bioconjugation: A Perspective from the Pharmaceutical Industry. JACS Au, 3(5): 1267–1283. https://doi.org/10.1021/jacsau.2c00617